Archives — June 2017 back to current month (46)
Laidlaw & Company initiated coverage with a Buy rating and target price of $18 on a company that is repurposing an approved cannabinoid to fulfill unmet medical needs.
With gold production progressing better than expected, this miner has revised its guidance for FY/17.
A Canadian company with its lead drug candidate in a Phase 3 trial recently closed an offering that raised CA$10 million for future research, which has one analyst contemplating the potential for "3x upside."
Rick Mills, editor of Ahead of the Herd, discusses the myriad ways the use of drones benefits the agriculture industry, and lays out his investment thesis for a company he believes is poised to profit from the technology.
Gold and Silver Juniors: Extreme Value Moment (06/28/2017)
The GDXJ rebalancing is shaking out speculators and opening the sector up to new blood, opines Tom Beck, founder of Portfolio Wealth Global.
A junior explorer has taken back the reins of a project in Portugal that is showing results.
The Coming Battery Bonanza (06/26/2017)
James Dines, author of The Dines Letter, discusses the importance of graphite in the manufacture of lithium-ion batteries and highlights one graphite company he expects to have an edge.
Thank You, GDXJ: Ultimate Rebalance Victim Trade (06/26/2017)
Lior Gantz, editor of Wealth Research Group, discusses the GDXJ rebalance and its significance for one company.
Myopic Metals and Miner Miasma (06/26/2017)
"Generally accepted narrative" can get in the way of making investment decisions, says precious metals expert Michael Ballanger.
King's Wealth: Gold Stocks Playbook Part 2 (06/25/2017)
This is Part 2 of the King's Wealth: The Complete Gold and Silver Stocks Playbook, by Tom Beck, founder of Portfolio Wealth Global, that will continue over the next seven weeks.
Jack Chanís Weekly Precious Metals Update (06/24/2017)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets, and believes the ongoing consolidation may end soon.
Good News Pouring In for a British Columbia Miner (06/22/2017)
Once again analysts are talking about this British Columbia mining company that just announced its first gold pour.
A San Diego-based pharmaceutical company that focuses on over-the-counter medications reported strong Q1/17 results and expects to begin marketing a nasal spray by the end of the year.
The acquisition of the Toughnut Project in British Columbia would provide strategic access to the Silver King Shear Zone adjacent to the explorer's existing properties.
Exploration on its Quebec property is up next for this junior after raising money from some prominent players, says The Critical Investor in this company update.
A winter drilling program at Patterson Lake South in Canada's uranium-rich Athabasca Basin has confirmed high grades of mineralization on one company's property, and suggests the mineralized trend may be extendable.
Dollar Update (06/20/2017)
The U.S. dollar has held up better than expected, says technical analyst Clive Maund, as he discusses its downside potential.
Jack Chanís Weekly Precious Metals Update (06/18/2017)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets, noting signs that gold stocks are near the end of their corrective consolidation.
GDXJ Massacre: The Aftermath (06/18/2017)
Veteran investor Bill Gross' investment strategy offers lessons to all investors, says Lior Gantz, editor of Wealth Research Group.
King's Wealth: Gold Stocks Playbook Part 1 (06/18/2017)
This is Part 1 of the King's Wealth: The Complete Gold and Silver Stocks Playbook, a series by Tom Beck, founder of Portfolio Wealth Global, that will continue over the next eight weeks.
Winter drilling in the Athasbasca Basin has revealed significant mineralization and off-scale radioactivity, as well as the opportunity for mineral resource expansion, and analysts now await the preliminary economic assessment that is expected shortly.
Dr. Drone (06/15/2017)
Rick Mills, editor of Ahead of the Herd, discusses how he sees drones upending business models and reshaping industry landscapes, including agriculture.
The latest set of drill results seems to solidify this deposit's reputation as a Tier 1 zinc asset in the making, says The Critical Investor in this update.
Now that the FDA has lifted its clinical hold on Phase 3 study of Inovio Pharmaceutical's immunotherapy for cervical dysplasia, three analysts are making note of what the progress means for both the company and investors.
Two well-known mining companies are combining efforts to bring a mine into production in Argentina, currently a mining hot spot.
One Massive, Global, Serial Bubble (06/13/2017)
Precious metals expert Michael Ballanger reflects on the state of the stock and bond markets and their effect on the gold market.
Cryptocurrencies: Intrinsic Value Boil Down (06/11/2017)
Bitcoin and other cryptocurrencies have exploded in value since their genesis in 2009; Lior Gantz, editor of Wealth Research Group, discusses the reasons why.
With the zinc market on the verge of a potentially huge supply deficit, The Critical Investor examines Vendetta Mining's Pegmont lead-zinc project in Australia.
Jack Chan's Weekly Gold and Silver Market Update (06/10/2017)
Technical analyst Jack Chan charts the week's movement in the gold and silver markets, continuing to track a multimonth correction.
Gold: On the Verge of Tearing Up Resistance (06/09/2017)
Gold is on the way up, says Tom Beck, editor of Portfolio Wealth Global, and sets out several elements investors should look for before buying.
Shaking off delays in April, this mining and development company has money to expand, and analysts are talking about the Nevada project's May production results.
Osisko Gold Acquisition Offers Strong Growth (06/08/2017)
Osisko Gold Royalties announced the acquisition of a portfolio of royalties and streams from Orion Mine Finance earlier this week. Fund manager Adrian Day says the numbers clearly show the value of the transaction.
Osisko Joins the Big League (06/07/2017)
Money manager Adrian Day examines Osisko Gold Royalties' purchase of Orion Mine Finance's portfolio, which he views as transformational.
The potential of RXi Pharmaceuticals' sd-rxRNA technology in the development of cancer immunotherapies has resulted in an extension of its research collaboration with Oslo-based PCI Biotech and captured the attention of two analysts.
This Cobalt Junior Could Have the Winning Formula (06/07/2017)
With a global shortage of cobalt predicted, Global Energy Metals has agreements in place that both secure supply and secure access to end-users.
Commissioning Complete at Mexican Mine (06/06/2017)
With the commissioning phase of the processing plant complete, full production at this Mexican mine has resumed.
With primary targets still not accessible due to weather, secondary targets are the focus, and analysts Ryan Walker of Echelon Wealth Partners and Adam Melnyk of PI Financial weigh in on the latest results.
Gold Breaks Out (06/06/2017)
Rudi Fronk and Jim Anthony, the cofounders of Seabridge Gold, discuss the significance of gold breaching its downward sloping trend line.
The Sun Rises on the Precious Metals Sector (06/05/2017)
A bull market is incubating in the precious metals section, and technical analyst Clive Maund has charted trends that investors should be watching.
Silver: A Real Breakout Is Coming (06/04/2017)
Silver bull Lior Gantz, editor of Wealth Research Group, discusses why he places silver at the top of his natural resource rankings.
Tom Beck, editor of Portfolio Wealth Global, discusses why he believes inflation will increase and steps investors can take to protect themselves.
Technical analyst Jack Chan charts the latest moves in the oil and gas markets.
Jack Chanís Weekly Gold and Silver Market Update (06/04/2017)
Technical analyst Jack Chan charts the latest moves in the precious metals markets, noting a new major sell signal in the USD, which supports metal prices.
Keep Calm and Carry On (06/02/2017)
As precious metals expert Michael Ballanger ponders the current markets, he vows to "Keep Calm and Carry On."
Positive Results Boost Stocks, but Still Some Buys (06/01/2017)
Money manager Adrian Day reviews the current news from five companies and reflects on prospects for return on investment.
BMO Analyst Andrew Kaip highlights what to expect from this developer in the near and more-distant future with a rating upgrade.
|"Final results at NXE's Rook 1 point to the quality of the project."|
|"As of Sept. 30, 2017, POE had no debt and $40M of cash."|
|"We are resuming coverage on WPM with a Buy."|
|"RXII's sd-rxRNA can augment already amazing results in immunotherapy."|